Concepedia

Fatma Şanli

FŞ

Statistics

Publications

6

Citations

112

H-Index

6

Active since

2019

Affiliations

Erzurum Technical University(Current)

Atatürk University

Michael E. DeBakey VA Medical Center

Baylor College of Medicine

Fatma Şanli is an author at Erzurum Technical University specializing in oncology, molecular oncology, and malignant neoplasms.

Publications per year

2019–2021

6

Publications

6

CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis

Özel Çapik, Fatma Şanli, Ali Kurt et al. · Prostate Cancer and Prostatic Diseases · 2021 · 26 citations

Medicine, Cancer Biology, Oncology +14

Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents

Derya Aktaş, Gökçen Akinalp, Fatma Şanli et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer

Neslisah Barlak, Özel Çapik, Fatma Şanli et al. · Cell Biology International · 2019 · 20 citations

Life Sciences, Molecular Biology, Oncology +17

AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer

Abdulmelik Aytatlı, Neslisah Barlak, Fatma Şanli et al. · Cellular Oncology · 2021 · 20 citations · Full text

Medicine, Oncology, Pharmacology +10

Mode of action of carboplatin via activating p53/miR‐145 axis in head and neck cancers

Neslisah Barlak, Fatma Şanli, Abdulmelik Aytatlı et al. · The Laryngoscope · 2019 · 14 citations

Medicine, Oncology, Pharmacology +17

1–5 of 6